It was clear that miR32 could target PTEN to affect multiple carcinoma progress, such as hepatocellular carcinoma and colorectal cancer [29,31], andmiR-32 activatesPI3K signaling by targeting PTEN in bone marrow-derived mesenchymal stem cells [28]. This evidence concerns the gene PTEN and hepatocellular carcinoma.